Nov 12 2009
Camstar Systems, Inc. announced today that Pacific Biosciences, a leader in the development of a transformative Single Molecule Real Time (SMRT™) DNA sequencing platform, has selected the Camstar Manufacturing™ enterprise software platform to enable its critical transition from product development to high-volume production, and to ensure consistent top product quality.
As an industry innovator, Pacific Biosciences is growing rapidly, and the scalable manufacturing platform will enable the company to shorten time-to-volume and rapidly develop, roll out and enforce best practices across new production lines and plants.
“Pacific Biosciences is committed to delivering innovative products with the highest price performance in the industry,” said Bruce Leisz, Vice President of Operations and Program Management for Pacific Biosciences. “Camstar’s manufacturing execution platform will provide visibility and consistent control over our expanding manufacturing processes and resources. Access to a rich set of intelligence about our processes accelerates our ability to continuously innovate and improve.”
“Camstar is seeing rapid adoption of our solutions across the most innovative Diagnostics and Biotechnology industries,” said Jason Adams, Camstar’s Vice President of Sales for North America and Europe. “As companies commercialize their breakthrough products, they realize that achieving consistently high product quality in the midst of highly complex processes requires a comprehensive platform for manufacturing execution and quality.”
See Camstar’s Enterprise Platform for Advancing Product Quality, configured specifically for Biotechnology.
Source: Camstar Systems, Inc.
Adeno-associated virus: The gene therapy revolution faces manufacturing and safety hurdles